Skip to main content

Table 1 Description of the training and test series considered with number of samples/outliers

From: Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling

TRAINING SERIES
Series Platform Technology Quality samples Excluded outliers Samples origin
GSE52712 Affymetrix Microarray 19 1 Manchester (UK)
GSE40987 Affymetrix Microarray 10 0 Boston (USA)
GSE52262 Affymetrix Microarray 16 0 Houston (USA)
GSE12790 Affymetrix Microarray 20 1 San Francisco (USA)
GSE46834 Illumina Microarray 8 0 New York (USA)
GSE68651 Illumina Microarray 35 1 Southampton (UK)
GSE74251 Illumina RNA-Seq 12 0 Philadelphia (USA)
GSE74377 Illumina RNA-Seq 12 0 Iowa (USA)
TOTAL Integrated   132 3  
TEST SERIES
Series Platform Technology Quality samples Excluded outliers Samples origin
GSE78011 Illumina RNA-Seq 3 0 Louisville (USA)
GSE81593 Illumina RNA-Seq 3 0 New York (USA)
GSE75292 Illumina Microarray 6 1 Goyang (South Korea)
GSE29327 Affymetrix Microarray 6 0 South San Francisco (USA)
GSE30931 Illumina Microarray 12 0 Goettingen (Germany)
GSE48398 Illumina Microarray 36 0 Texas (USA)
GSE35928 Affymetrix Microarray 6 0 Piscataway (USA)
GSE57339 Illumina Microarray 12 0 New Haven (USA)
GSE45715 Illumina Microarray 42 0 Miami (USA)
TOTAL Integrated   126 1